Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Carlos Silva, MS
Associate Director, Pharmacokinetics
AstraZeneca plc, United Kingdom
Poster(s):
026: Phase I Open Label Study to Evaluate the Effects of Savolitinib on the Pharmacokinetics of P-gp, OATP1B1/3, OCT2, MATE1/2K & OAT1/3 Substrates in Healthy Volunteers
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
124: A Drug-Drug Interaction Study to Evaluate the Impact of Coadministration of AZD0780 on Rosuvastatin Exposure in Healthy Participants
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
